
Tiffany Braley, M.D., M.S.
Director, Division of Multiple Sclerosis and Neuroimmunology
Holtom-Garrett Family Professor of Neurology
A new survey shows high usage rates of cannabinoids like CBD for multiple sclerosis, but most patients are figuring out these new products on their own.